Tuesday, February 12, 2013- Merck's Crash of a Titanat Motley Fool (Tue, Feb 12)
- Sanofi Shows Interest in RegeneronZacks (Tue, Feb 12)
- Bayer Seeks Riociguat ApprovalZacks (Tue, Feb 12)
- Cardiome Selects QuintilesZacks (Tue, Feb 12)
- Can These 3 Stocks Be Resurrected?at Motley Fool (Tue, Feb 12)
- After The Twists And Turns, Sanofi Still A Valueat Seeking Alpha (Tue, Feb 12)
- 4 Healthcare Stock Stories for Tuesday Wellnessat Wall St. Cheat Sheet (Tue, Feb 12)
- What’s Moving These Biotech Stocks?at Motley Fool (Tue, Feb 12)
- Pipeline Progresses at ShireZacks (Tue, Feb 12)
- 4 Stocks Pushing The Health Care Sector Higherat TheStreet (Tue, Feb 12)
- We Love You, Just Not Enough to Buy You (Yet)at Motley Fool (Tue, Feb 12)
- Zacks Bull and Bear of the Day Highlights: Tyson Foods, Goldcorp, Novo Nordisk, Sanofi and BayerZacks (Tue, Feb 12)
Monday, February 11, 2013- Microsoft Jumped, but the Dow Fell Anywayat Motley Fool (Mon, Feb 11)
- Acorda Presents Encouraging DataZacks (Mon, Feb 11)
- The Best Dividend in Big Pharmaat Motley Fool (Mon, Feb 11)
- Novo Nordisk Hit By Diabetes Drug Delay; Sanofi Risesat Investor's Business Daily (Mon, Feb 11)
- Pipeline Advances at GlaxoZacks (Mon, Feb 11)
- Novo Nordisk Suffers SetbackZacks (Mon, Feb 11)
- Update on Lilly's TabalumabZacks (Mon, Feb 11)
- Midday Movers: REGN, FOSL & Moreat CNBC (Mon, Feb 11)
- Why Regeneron Pharmaceuticals Shares Spikedat Motley Fool (Mon, Feb 11)
- Stocks Narrow To Thin Red Line; Generac Backslidesat Investor's Business Daily (Mon, Feb 11)
- [video] European Stocks Weighed Down by Novo Nordiskat CNBC (Mon, Feb 11)
- Novo Nordisk Fails, Sanofi and Lilly Winat Motley Fool (Mon, Feb 11)
- Novo Nordisk Stock Falls, Sanofi Rises On Drug Delayat Investor's Business Daily (Mon, Feb 11)
Add SNY News to My Yahoo!   | |
|
0.29(0.53%) May 17, 4:00PM EDT